biovinc.com
Get leads like Biovinc — and thousands more
Build targeted lists by tech stack, traffic, and more
BioVinc: The Stealth Biotech Targeting $1.5B PJI Market
A 5-person team with $0.8M revenue tackling prosthetic joint infections with precision diagnostics
While big pharma chases blockbusters, BioVinc is surgically targeting a $1.5 billion niche that kills 28,000 Americans annually. With just 5 employees and $0.8M in revenue, they're building the precision tool that could make prosthetic joint infections (PJI) obsolete.
"They're not building another antibiotic—they're building the diagnostic that tells surgeons exactly which bone is infected and where."
The $1.5B Problem They Own
Prosthetic joint infections affect 250,000 patients annually in the US alone, with treatment costs averaging $100,000 per case. BioVinc's approach isn't about creating another broad-spectrum antibiotic—it's about developing bone-disease selective therapeutics and diagnostics that can precisely identify infected bone tissue. Their flagship probe technology (referenced in top keyword 'probe bone' with 490 monthly searches) suggests they're targeting specific biomarkers that only activate in infected bone environments.
The 5-Person Powerhouse
This isn't your typical biotech with 200+ employees. BioVinc's lean team includes Shuting Sun (COO), Hal Ebetino (President), Philip Cherian (Senior Research Chemist), and Tom Wolfe (Advisory Board Chairman). The presence of a dedicated research chemist alongside C-suite leadership suggests they're in active R&D phase, likely validating their diagnostic platform. With $0.8M revenue from just 5 people, they're generating $160K per employee—a strong efficiency ratio for a pre-revenue biotech.
Their tech stack reveals a pragmatic, cost-conscious approach. Built on WordPress with Tailwind CSS and Bootstrap, they're prioritizing rapid iteration over custom engineering. The use of jQuery and core-js suggests legacy code maintenance, but the presence of Google Analytics and lazy loading shows they're data-driven about user acquisition. Their 34% organic search traffic indicates they're starting to rank for niche medical keywords, though their global rank of #13.6M shows they're still in stealth mode.
- Keyword dominance: 'biovinc' (160 searches) and 'af647' (170 searches) suggest proprietary chemistry or diagnostic markers
- Traffic paradox: 39% direct traffic with only 1K monthly visits indicates highly targeted, referral-based acquisition
- Social proof: YouTube and LinkedIn presence suggests they're building thought leadership in orthopedic circles
- Geographic mystery: 'undefined' countries account for 100% of traffic—likely either bot traffic or they're hiding their true market focus
The Stealth Bet on Precision Medicine
BioVinc isn't chasing the antibiotic apocalypse—they're building the surgical precision tool that makes infections impossible to miss. For investors: this is a $0.8M revenue bet on a $1.5B market. For founders: this is how you build biotech without burning $50M. The question isn't whether they'll succeed—it's whether they'll stay this lean while scaling.
What tech stack does Biovinc use?
How much traffic does Biovinc get?
Traffic & Engagement
Traffic Sources
Where is Biovinc's audience located?
What keywords does Biovinc rank for?
3 keywordsHow is Biovinc's SEO?
Open Graph Image
https://biovinc.com/wp-content/uploads/2025/02/BioVinc-OG.png
Meta Tags
Home - BioVinc
BioVinc is a leader in the development of novel bone disease selective therapeutics and diagnostics.
H1 Tags
Schema Types
What is Biovinc's revenue?
Who works at Biovinc?
Loading leads...
What do customers think of Biovinc?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Biovinc
What is Biovinc's Revenue?
What does Biovinc do?
How fast is Biovinc growing?
What technologies does Biovinc use?
Who are Biovinc's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Biovinc?
Contact Information
Export biovinc.com Data
Download the complete tech stack, analytics, leads, and company data for biovinc.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About biovinc.com
BioVinc is a leader in the development of novel bone disease selective therapeutics and diagnostics.
Company Overview
biovinc.com Social Media
Contact biovinc.com
Email Addresses
Phone Numbers
Technology Stack
biovinc.com uses 11 technologies across their website including Font Awesome, PHP, WordPress, and more.
Fonts
Font Awesome
Programming Languages
PHP
CMS
WordPress
Analytics & Marketing
Google Analytics
Performance
Lazy Loading
Web Standards
Twitter Cards, RSS
Traffic & Audience
biovinc.com receives approximately 1.0K monthly visitors and ranks #13,602,589 globally. The website has a bounce rate of 39% with visitors viewing an average of 1.4 pages per visit. Users spend an average of 0:15 on the site.
The majority of biovinc.com's traffic comes from undefined, .
Frequently Asked Questions
What is biovinc.com?
What technologies does biovinc.com use?
How do I contact biovinc.com?
What are biovinc.com's social media accounts?
How popular is biovinc.com?
Related Searches
This page provides publicly available information about biovinc.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit biovinc.com directly at https://biovinc.com.